Topiramate Tablet, Film Coated
Product Images NDC 87441-079

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 87441-079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topiramate 25 mg (8744107901 Topiramate 25 mg)

Topiramate tablets, USP, 25 mg film-coated oral tablets with NDC 87441-079-01. The label includes directions for pharmacists to dispense the medication guide and notes storage temperature between 20° to 25°C. Repacks by Unit Dose Solutions, Inc., Raleigh, NC, and distributed by Tuckhoe Enterprises, LLC, Henrico, VA. Barcode and lot, expiration, quantity fields are present but not filled.*

FDA Label Image

Figure1 (Figure1)

A Kaplan-Meier plot showing cumulative rates for time to first seizure over 500 days for Topiramate doses of 50 mg/day (solid line) and 400 mg/day (dotted line). The y-axis shows cumulative seizure rates, and the x-axis shows time in days. The graph includes sample sizes and a statistical significance value (p = 0.0002).*

FDA Label Image

Figure2 (Figure2)

A bar chart showing the change from baseline to double-blind phase in average monthly migraine period rate (+SE) for placebo and three Topiramate dosages: 50 mg/day, 100 mg/day, and 200 mg/day. Results are shown for two studies, Study 11 and Study 12, with significant reductions marked at p<0.010 and p<0.001 levels.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of topiramate, the active ingredient shown as a molecular formula with labeled atoms and bonds.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.